Health Sciences Acquisitions Corporation 2 40 10th Avenue, Floor 7 New York, NY 10014 Chardan Capital Markets, LLC 17 State Street New York, NY 10004 Re: Initial Public Offering Ladies and Gentlemen:Letter Agreement • August 7th, 2020 • Health Sciences Acquisitions Corp 2 • Blank checks • New York
Contract Type FiledAugust 7th, 2020 Company Industry JurisdictionThis letter (the “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and between Health Sciences Acquisitions Corporation 2, a Cayman Islands exempted company (the “Company”) and Chardan Capital Markets, LLC (the “Representative”), relating to an underwritten initial public offering (the “IPO”) of the Company’s ordinary shares, par value $0.0001 per share (the “Ordinary Shares”). Certain capitalized terms used herein are defined in paragraph 13 hereof.
Health Sciences Acquisitions Corporation 2 40 10th Avenue, Floor 7 New York, NY 10014 Chardan Capital Markets, LLC 17 State Street New York, NY 10004 Re: Initial Public Offering Ladies and Gentlemen:Letter Agreement • July 24th, 2020 • Health Sciences Acquisitions Corp 2 • Blank checks
Contract Type FiledJuly 24th, 2020 Company IndustryThis letter (the “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and between Health Sciences Acquisitions Corporation 2, a Cayman Islands exempted company (the “Company”) and Chardan Capital Markets, LLC (the “Representative”), relating to an underwritten initial public offering (the “IPO”) of the Company’s ordinary shares, par value $0.0001 per share (the “Ordinary Shares”). Certain capitalized terms used herein are defined in paragraph 13 hereof.